Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
Authors
Keywords
-
Journal
JAMA Ophthalmology
Volume -, Issue -, Pages -
Publisher
American Medical Association (AMA)
Online
2021-02-26
DOI
10.1001/jamaophthalmol.2020.7085
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Using an excel spreadsheet to convert Snellen visual acuity to LogMAR visual acuity
- (2020) Stephenie Tiew et al. EYE
- Brolucizumab: Evolution through Preclinical and Clinical Studies and the Implications for the Management of Neovascular Age-Related Macular Degeneration
- (2020) Quan Dong Nguyen et al. OPHTHALMOLOGY
- Brolucizumab and immunogenicity
- (2020) Ashish Sharma et al. EYE
- Retinal vasculitis and intraocular inflammation after intravitreal injection of brolucizumab
- (2020) Caroline R. Baumal et al. OPHTHALMOLOGY
- HAWK and HARRIER
- (2020) Pravin U. Dugel et al. OPHTHALMOLOGY
- HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
- (2019) Pravin U. Dugel et al. OPHTHALMOLOGY
- Brolucizimab—leading an era of structural revolution for long-term VEGF suppression
- (2019) Ashish Sharma et al. EYE
- Brolucizumab: First Approval
- (2019) Anthony Markham DRUGS
- Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial
- (2017) Pravin U. Dugel et al. OPHTHALMOLOGY
- SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB
- (2017) Robert L. Avery et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration
- (2016) Frank G. Holz et al. OPHTHALMOLOGY
- Postmarketing Analysis of Aflibercept-Related Sterile Intraocular Inflammation
- (2015) Paul Hahn et al. JAMA Ophthalmology
- Noninfectious Inflammation After Intravitreal Injection of Aflibercept: Clinical Characteristics and Visual Outcomes
- (2014) Roger A. Goldberg et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ocular and systemic safety of bevacizumab and ranibizumab in patients with neovascular age-related macular degeneration
- (2013) Davin Johnson et al. CURRENT OPINION IN OPHTHALMOLOGY
- World Medical Association Declaration of Helsinki
- (2013) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vitreous Inflammation Associated with Intravitreal Anti-VEGF Pharmacotherapy
- (2013) Shivi Agrawal et al. MEDIATORS OF INFLAMMATION
- Aflibercept-Related Sterile Inflammation
- (2013) Paul Hahn et al. OPHTHALMOLOGY
- NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTS
- (2010) Ninel Z Gregori et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started